聚合物载体与棕榈酸共轭小干扰RNA之间的疏水相互作用可提高聚乙二醇化多聚体的稳定性,并增强体内药代动力学和肿瘤基因沉默效果。
Hydrophobic interactions between polymeric carrier and palmitic acid-conjugated siRNA improve PEGylated polyplex stability and enhance in vivo pharmacokinetics and tumor gene silencing.
作者信息
Sarett Samantha M, Werfel Thomas A, Chandra Irene, Jackson Meredith A, Kavanaugh Taylor E, Hattaway Madison E, Giorgio Todd D, Duvall Craig L
机构信息
Department of Biomedical Engineering, Vanderbilt Institute for Nanoscale Science and Engineering, Vanderbilt University School of Engineering, Nashville, TN 37232, USA.
Department of Biomedical Engineering, Vanderbilt Institute for Nanoscale Science and Engineering, Vanderbilt University School of Engineering, Nashville, TN 37232, USA.
出版信息
Biomaterials. 2016 Aug;97:122-32. doi: 10.1016/j.biomaterials.2016.04.017. Epub 2016 Apr 21.
Formation of stable, long-circulating siRNA polyplexes is a significant challenge in translation of intravenously-delivered, polymeric RNAi cancer therapies. Here, we report that siRNA hydrophobization through conjugation to palmitic acid (siPA) improves stability, in vivo pharmacokinetics, and tumor gene silencing of PEGylated nanopolyplexes (siPA-NPs) with balanced cationic and hydrophobic content in the core relative to the analogous polyplexes formed with unmodified siRNA, si-NPs. Hydrophobized siPA loaded into the NPs at a lower charge ratio (N(+):P(-)) relative to unmodified siRNA, and siPA-NPs had superior resistance to siRNA cargo unpackaging in comparison to si-NPs upon exposure to the competing polyanion heparin and serum. In vitro, siPA-NPs increased uptake in MDA-MB-231 breast cancer cells (100% positive cells vs. 60% positive cells) but exhibited equivalent silencing of the model gene luciferase relative to si-NPs. In vivo in a murine model, the circulation half-life of intravenously-injected siPA-NPs was double that of si-NPs, resulting in a >2-fold increase in siRNA biodistribution to orthotopic MDA-MB-231 mammary tumors. The increased circulation half-life of siPA-NPs was dependent upon the hydrophobic interactions of the siRNA and the NP core component and not just siRNA hydrophobization, as siPA did not contribute to improved circulation time relative to unmodified siRNA when delivered using polyplexes with a fully cationic core. Intravenous delivery of siPA-NPs also achieved significant silencing of the model gene luciferase in vivo (∼40% at 24 h after one treatment and ∼60% at 48 h after two treatments) in the murine MDA-MB-231 tumor model, while si-NPs only produced a significant silencing effect after two treatments. These data suggest that stabilization of PEGylated siRNA polyplexes through a combination of hydrophobic and electrostatic interactions between siRNA cargo and the polymeric carrier improves in vivo pharmacokinetics and tumor gene silencing relative to conventional formulations that are stabilized solely by electrostatic interactions.
形成稳定、长循环的siRNA多聚体是静脉注射的聚合物RNAi癌症疗法转化过程中的一项重大挑战。在此,我们报告称,通过与棕榈酸结合使siRNA疏水化(siPA)可提高聚乙二醇化纳米多聚体(siPA-NPs)的稳定性、体内药代动力学以及肿瘤基因沉默效果,与由未修饰的siRNA形成的类似多聚体(si-NPs)相比,siPA-NPs核心中的阳离子和疏水成分含量平衡。相对于未修饰的siRNA,以较低的电荷比(N(+):P(-))将疏水化的siPA加载到纳米颗粒中,并且与si-NPs相比,在暴露于竞争性聚阴离子肝素和血清时,siPA-NPs对siRNA货物解包具有更强的抗性。在体外,siPA-NPs增加了MDA-MB-231乳腺癌细胞的摄取(阳性细胞为100%,而si-NPs为60%阳性细胞),但相对于si-NPs,对模型基因荧光素酶的沉默效果相当。在小鼠模型体内,静脉注射的siPA-NPs的循环半衰期是si-NPs的两倍,导致siRNA在原位MDA-MB-231乳腺肿瘤中的生物分布增加了两倍以上。siPA-NPs循环半衰期的增加取决于siRNA与纳米颗粒核心成分的疏水相互作用,而不仅仅是siRNA的疏水化,因为当使用具有完全阳离子核心的多聚体递送时,相对于未修饰的siRNA,siPA对循环时间的改善没有贡献。在小鼠MDA-MB-231肿瘤模型中,静脉注射siPA-NPs在体内也实现了对模型基因荧光素酶的显著沉默(一次治疗后24小时约为40%,两次治疗后48小时约为60%),而si-NPs仅在两次治疗后才产生显著的沉默效果。这些数据表明,相对于仅通过静电相互作用稳定的传统制剂,通过siRNA货物与聚合物载体之间的疏水和静电相互作用相结合来稳定聚乙二醇化siRNA多聚体可改善体内药代动力学和肿瘤基因沉默效果。